ANAB
AnaptysBio Inc
NASDAQ: ANAB · HEALTHCARE · BIOTECHNOLOGY
$65.73
+5.44% today
Updated 2026-04-30
Market cap
$1.81B
P/E ratio
—
P/S ratio
7.73x
EPS (TTM)
$-0.46
Dividend yield
—
52W range
$11 – $72
Volume
0.6M
AnaptysBio Inc (ANAB) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-5.80M | $14.60M | $-9.67M | $-9.03M | $-19.44M | $-48.51M | $-69.52M | $-14.16M | $-45.92M | $-73.59M | $-120.80M | $-135.34M | $19.70M |
| Capital expenditures | $37000.00 | $145000.00 | $238000.00 | $50000.00 | $290000.00 | $1.06M | $805000.00 | $569000.00 | $1.37M | $358000.00 | $807000.00 | $358000.00 | $87000.00 |
| Depreciation | $580000.00 | $308000.00 | $274000.00 | $233000.00 | $183000.00 | $315000.00 | $514000.00 | $559000.00 | $2.09M | $2.33M | $2.38M | $2.40M | — |
| Stock-based comp | $151000.00 | $160000.00 | $604000.00 | $1.16M | $4.38M | $9.96M | $12.41M | $11.50M | $15.35M | $27.36M | $33.20M | $34.05M | $36.07M |
| Free cash flow | $-5.83M | $14.46M | $-9.91M | $-9.08M | $-19.73M | $-49.57M | $-70.32M | $-14.73M | $-47.29M | $-73.95M | $-121.61M | $-135.69M | $19.61M |
| Investing cash flow | $-37000.00 | $-140000.00 | $-238000.00 | $-50000.00 | $-243.06M | $-142.45M | $131.43M | $94.47M | $38.84M | $-394.85M | $144.75M | $95.40M | — |
| Financing cash flow | $1.96M | $4.92M | $39.40M | $8.63M | $292.45M | $223.36M | $-4.49M | $-879000.00 | $252.30M | $44.02M | $-59.30M | $127.05M | — |
| Dividends paid | — | — | — | — | $0.00 | — | — | — | — | — | $11.73M | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | $29.96M | $32.41M | $57.42M | $79.44M | $245.21M | $-424.42M | — | — | — |